Nitta Gelatin India Ltd

Nitta Gelatin India Ltd

₹ 843 0.98%
24 Jun - close price
About

Incorporated in 1975, Nitta Gelatin India Ltd manufactures and sells ossein, gelatin, and collagen peptide[1]

Key Points

Business Overview:[1]
NGIL, a joint venture between the Kerala State Industrial Development Corporation (32% shareholding) and Osaka-based NGI (43% stake), manufactures gelatin, ossein, limed ossein, and DCP from processed animal bones. It also produces collagen peptide-based consumer products for the pharmaceutical and healthcare industries.

  • Market Cap 765 Cr.
  • Current Price 843
  • High / Low 1,184 / 697
  • Stock P/E 9.26
  • Book Value 378
  • Dividend Yield 0.89 %
  • ROCE 34.8 %
  • ROE 27.0 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 89.2% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.3%

Cons

  • The company has delivered a poor sales growth of 11.9% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
105 106 119 139 142 134 146 140 146 128 140 134 130
98 98 108 117 119 113 119 102 119 90 108 102 110
Operating Profit 7 8 11 22 22 21 27 38 27 39 31 32 20
OPM % 7% 8% 10% 16% 16% 16% 19% 27% 18% 30% 22% 24% 15%
1 1 1 1 1 1 0 3 0 3 3 0 5
Interest 1 1 1 1 1 1 2 1 0 0 0 0 2
Depreciation 4 4 4 4 4 3 4 4 4 4 4 4 4
Profit before tax 3 5 8 18 18 18 22 36 23 38 30 29 20
Tax % 31% 26% 35% 28% 29% 28% 29% 21% 27% 25% 27% 28% 33%
2 4 5 13 13 13 15 29 17 28 22 21 13
EPS in Rs 2.40 3.71 5.19 13.93 13.44 13.48 16.11 30.02 17.82 30.32 23.45 21.90 15.36
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
303 287 354 357 356 342 303 342 396 506 565 533
260 271 330 321 320 313 273 306 351 442 452 410
Operating Profit 43 16 24 36 36 29 30 36 45 64 114 123
OPM % 14% 5% 7% 10% 10% 8% 10% 10% 11% 13% 20% 23%
2 0 2 2 9 5 1 2 1 5 4 11
Interest 9 8 10 8 7 7 9 8 6 5 4 2
Depreciation 16 17 14 13 14 15 15 16 16 14 14 15
Profit before tax 20 -9 1 18 24 12 7 13 25 49 99 116
Tax % 55% 23% 358% 53% 49% 61% 33% 8% 29% 29% 25% 28%
11 -7 -4 9 12 5 5 12 18 35 74 84
EPS in Rs 9.59 -6.71 -1.56 11.82 15.61 4.90 3.82 12.38 19.15 36.26 77.44 91.02
Dividend Payout % 31% 0% -64% 21% 16% 51% 39% 20% 16% 11% 10% 7%
Compounded Sales Growth
10 Years: 6%
5 Years: 12%
3 Years: 10%
TTM: -6%
Compounded Profit Growth
10 Years: 32%
5 Years: 89%
3 Years: 68%
TTM: 21%
Stock Price CAGR
10 Years: 18%
5 Years: 45%
3 Years: 62%
1 Year: 3%
Return on Equity
10 Years: 14%
5 Years: 20%
3 Years: 25%
Last Year: 27%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 8 9 9 9 9 9 9 9 9 9 9 9
Reserves 105 100 99 105 124 139 141 144 164 192 259 334
Preference Capital 0 0 0 16 0 0 0 0 0 4 4
57 68 66 76 109 104 108 84 80 82 35 14
52 49 49 65 59 54 55 57 53 62 64 65
Total Liabilities 222 226 223 256 301 306 313 294 306 345 367 423
117 125 118 120 110 113 130 121 113 107 114 114
CWIP 9 9 9 9 13 10 4 4 2 7 7 8
Investments 1 1 1 1 1 1 1 1 1 1 1 1
96 92 96 127 177 182 179 169 191 230 246 300
Total Assets 222 226 223 256 301 306 313 294 306 345 367 423

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
17 24 20 20 11 27 22 40 19 17 101 94
-13 -24 -8 -14 -3 -7 -14 -10 -7 -14 -18 -54
-3 0 -12 18 -5 -20 -7 -33 -12 -2 -55 -36
Net Cash Flow 1 -1 0 25 3 -0 1 -3 -0 1 28 4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 31 28 23 21 54 66 76 37 58 64 57 58
Inventory Days 140 131 100 114 144 153 191 205 161 136 126 156
Days Payable 58 72 51 42 48 53 59 49 43 28 39 44
Cash Conversion Cycle 113 87 72 93 150 165 209 193 176 172 144 170
Working Capital Days 66 62 54 58 97 94 108 78 107 113 90 97
ROCE % 17% -0% 6% 13% 14% 7% 6% 9% 12% 20% 33%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
74.48% 74.48% 74.48% 74.48% 74.48% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49% 74.49%
0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.12% 0.26% 0.26% 0.12% 0.12% 0.12%
25.40% 25.40% 25.40% 25.40% 25.40% 25.41% 25.41% 25.26% 25.26% 25.41% 25.40% 25.40%
No. of Shareholders 6,0146,5726,3576,3756,3997,5938,6508,3328,46610,18311,02811,573

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents